Jianle Mao

Shenzhen Metro (China)

Papers

2

Total Citations

10

H-Index

2

About

Jianle Mao is a pioneering surgeon-researcher at the forefront of robotic telesurgery, whose work is redefining the boundaries of remote surgical care. His primary research areas focus on the safety, reliability, and clinical efficacy of telesurgery, particularly within urology. Dr. Mao’s major contributions include leading landmark clinical trials that provide the first rigorous evidence for the non-inferiority of telesurgery compared to standard local procedures. His 2025 multicenter, single-arm phase I trial, cited 6 times, established the foundational safety profile of telesurgery in China. Building on this, his 2026 multicenter randomized controlled trial, with 4 citations, demonstrated that urological telesurgery is as reliable as in-person surgery, a pivotal finding for expanding healthcare access to remote and underserved regions. These achievements represent a significant leap forward in surgical robotics, offering a robust evidence base that could transform global surgical delivery. Dr. Mao’s work is not only technically ambitious but also strategically vital for the future of equitable healthcare, positioning him as a key figure in the next generation of surgical innovation.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Safety and reliability of telesurgery in China: a multicenter, single-arm, phase I clinical trial
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 45
🏛 Institutions: Shenzhen Metro (China)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago